UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 297

Sortiert nach

Trail receptors: targets for cancer therapy

Advances in experimental medicine and biology, 2008, Vol.615, p.127

2008

Link zum Volltext

Verfügbarkeit prüfen

Phase II Trial of Mapatumumab, a Fully Human Agonist Monoclonal Antibody to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor 1 (TRAIL-R1), in Combination With Paclitaxel and Carboplatin in Patients With Advanced Non–Small-Cell Lung Cancer

Clinical lung cancer, 2014-05, Vol.15 (3), p.188-196.e2

2014

Link zum Volltext

Verfügbarkeit prüfen

Sorafenib sensitizes solid tumors to Apo2L/TRAIL and Apo2L/TRAIL receptor agonist antibodies by the Jak2-Stat3-Mcl1 axis

PloS one, 2013-09, Vol.8 (9), p.e75414

2013

Link zum Volltext

Verfügbarkeit prüfen

Mapatumumab and lexatumumab induce apoptosis in TRAIL-R1 and TRAIL-R2 antibody-resistant NSCLC cell lines when treated in combination with bortezomib

Molecular cancer therapeutics, 2009-02, Vol.8 (2), p.292-302

2009

Link zum Volltext

Verfügbarkeit prüfen

Tumor-derived Mutations in the TRAIL Receptor DR5 Inhibit TRAIL Signaling through the DR4 Receptor by Competing for Ligand Binding

The Journal of biological chemistry, 2007-09, Vol.282 (38), p.28189-28194

2007

Link zum Volltext

Verfügbarkeit prüfen

Deletion of Stat3 Blocks Mammary Gland Involution and Extends Functional Competence of the Secretory Epithelium in the Absence of Lactogenic Stimuli

Endocrinology (Philadelphia), 2002-09, Vol.143 (9), p.3641-3650

2002

Link zum Volltext

Verfügbarkeit prüfen

Mitomycin C potentiates TRAIL-induced apoptosis through p53-independent upregulation of death receptors: Evidence for the role of c-Jun N-terminal kinase activation

Cell cycle (Georgetown, Tex.), 2012-09, Vol.11 (17), p.3312-3323

2012

Link zum Volltext

Verfügbarkeit prüfen

A Double Hit to Kill Tumor and Endothelial Cells by TRAIL and Antiangiogenic 3TSR

Cancer research (Chicago, Ill.), 2009-05, Vol.69 (9), p.3856-3865

2009

Link zum Volltext

Verfügbarkeit prüfen

Prediction of proapoptotic anticancer therapeutic response in vivo based on cell death visualization and TRAIL death ligand-receptor interaction

Cancer biology & therapy, 2011-08, Vol.12 (4), p.335-348

2011

Link zum Volltext

Verfügbarkeit prüfen

Spectral imaging-based methods for quantifying autophagy and apoptosis

Cancer biology & therapy, 2011-08, Vol.12 (4), p.349-356

2011

Link zum Volltext

Verfügbarkeit prüfen

Enhanced Apoptosis and Tumor Regression Induced by a Direct Agonist Antibody to Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Receptor 2

Clinical cancer research, 2005-04, Vol.11 (8), p.3126-3135

2005

Link zum Volltext

Verfügbarkeit prüfen

Transforming growth factor alpha and mouse models of human breast cancer

Oncogene, 2000-02, Vol.19 (8), p.1085-1091

2000

Link zum Volltext

Verfügbarkeit prüfen

Human monomeric antibody fragments to TRAIL-R1 and TRAIL-R2 that display potent in vitro agonism

mAbs, 2009-11, Vol.1 (6), p.552-562

2009

Link zum Volltext

Verfügbarkeit prüfen

Fusion toxin BLyS-gelonin inhibits growth of malignant human B cell lines in vitro and in vivo

PloS one, 2012-10, Vol.7 (10), p.e47361-e47361

2012

Link zum Volltext

Verfügbarkeit prüfen

Novel in vivo imaging shows up-regulation of death receptors by paclitaxel and correlates with enhanced antitumor effects of receptor agonist antibodies

Molecular cancer therapeutics, 2006-12, Vol.5 (12), p.2991-3000

2006

Link zum Volltext

Verfügbarkeit prüfen

Pediatric neurosurgery at the Hospital for Sick Children, The University of Toronto

Child's nervous system, 2012-08, Vol.28 (8), p.1127-1128

2012

Link zum Volltext

Verfügbarkeit prüfen

Retinal findings in children with intracranial hemorrhage

Ophthalmology (Rochester, Minn.), 2002-08, Vol.109 (8), p.1472-1476

2002

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4037: In vitro cytotoxicity of CPX-351 plus venetoclax compared with hypomethylating agents or cytarabine plus venetoclax

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.4037-4037

2020

Link zum Volltext

Verfügbarkeit prüfen

Proteasome inhibitors sensitize ovarian cancer cells to TRAIL induced apoptosis

Apoptosis (London), 2007-04, Vol.12 (4), p.635-655

2007

Link zum Volltext

Verfügbarkeit prüfen

Mammary Gland Development Is Mediated by Both Stromal and Epithelial Progesterone Receptors

Molecular endocrinology (Baltimore, Md.), 1997-06, Vol.11 (6), p.801-811

1997

Link zum Volltext

Verfügbarkeit prüfen

Enrique C. G. Ventureyra: 32nd president of the International Society for Pediatric Neurosurgery

Child's nervous system, 2006-07, Vol.22 (7), p.636-640

Humphreys, Robin P

2006

Link zum Volltext

Verfügbarkeit prüfen

RIP1 Protein-dependent Assembly of a Cytosolic Cell Death Complex Is Required for Inhibitor of Apoptosis (IAP) Inhibitor-mediated Sensitization to Lexatumumab-induced Apoptosis

The Journal of biological chemistry, 2012-11, Vol.287 (46), p.38767-38777

2012

Link zum Volltext

Verfügbarkeit prüfen

Measuring the health status of children with hydrocephalus by using a new outcome measure

Journal of neurosurgery, 2004-11, Vol.101 (2 Suppl), p.141

2004

Link zum Volltext

Verfügbarkeit prüfen

Endoscopic third ventriculostomy with cystoventricular stent placement in the management of Dandy-Walker malformation: Technical case report of three patients

Neurosurgery, 2003-11, Vol.53 (5), p.1223-1229

2003

Link zum Volltext

Verfügbarkeit prüfen

Spontaneous intraparenchymal hemorrhage in full-term neonates

Neurosurgery, 2001-05, Vol.48 (5), p.1042-1049

2001

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 297

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(274)
Mit Volltextzugriff
(234)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Trail receptors: targets for cancer therapy

Phase II Trial of Mapatumumab, a Fully Human Agonist Monoclonal Antibody to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor 1 (TRAIL-R1), in Combination With Paclitaxel and Carboplatin in Patients With Advanced Non–Small-Cell Lung Cancer

Sorafenib sensitizes solid tumors to Apo2L/TRAIL and Apo2L/TRAIL receptor agonist antibodies by the Jak2-Stat3-Mcl1 axis

Mapatumumab and lexatumumab induce apoptosis in TRAIL-R1 and TRAIL-R2 antibody-resistant NSCLC cell lines when treated in combination with bortezomib

Tumor-derived Mutations in the TRAIL Receptor DR5 Inhibit TRAIL Signaling through the DR4 Receptor by Competing for Ligand Binding

Deletion of Stat3 Blocks Mammary Gland Involution and Extends Functional Competence of the Secretory Epithelium in the Absence of Lactogenic Stimuli

Mitomycin C potentiates TRAIL-induced apoptosis through p53-independent upregulation of death receptors: Evidence for the role of c-Jun N-terminal kinase activation

A Double Hit to Kill Tumor and Endothelial Cells by TRAIL and Antiangiogenic 3TSR

Prediction of proapoptotic anticancer therapeutic response in vivo based on cell death visualization and TRAIL death ligand-receptor interaction

Spectral imaging-based methods for quantifying autophagy and apoptosis

Enhanced Apoptosis and Tumor Regression Induced by a Direct Agonist Antibody to Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Receptor 2

Transforming growth factor alpha and mouse models of human breast cancer

Human monomeric antibody fragments to TRAIL-R1 and TRAIL-R2 that display potent in vitro agonism

Fusion toxin BLyS-gelonin inhibits growth of malignant human B cell lines in vitro and in vivo

Novel in vivo imaging shows up-regulation of death receptors by paclitaxel and correlates with enhanced antitumor effects of receptor agonist antibodies

Pediatric neurosurgery at the Hospital for Sick Children, The University of Toronto

Retinal findings in children with intracranial hemorrhage

Abstract 4037: In vitro cytotoxicity of CPX-351 plus venetoclax compared with hypomethylating agents or cytarabine plus venetoclax

Proteasome inhibitors sensitize ovarian cancer cells to TRAIL induced apoptosis

Mammary Gland Development Is Mediated by Both Stromal and Epithelial Progesterone Receptors

Enrique C. G. Ventureyra: 32nd president of the International Society for Pediatric Neurosurgery

RIP1 Protein-dependent Assembly of a Cytosolic Cell Death Complex Is Required for Inhibitor of Apoptosis (IAP) Inhibitor-mediated Sensitization to Lexatumumab-induced Apoptosis

Measuring the health status of children with hydrocephalus by using a new outcome measure

Endoscopic third ventriculostomy with cystoventricular stent placement in the management of Dandy-Walker malformation: Technical case report of three patients

Spontaneous intraparenchymal hemorrhage in full-term neonates

Suchergebnisse filtern